{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1131, 
        1140
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1341, 
        1364
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1810, 
        1830
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        953, 
        980
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        941, 
        943
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        574, 
        603
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        886, 
        912
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        914, 
        920
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        944, 
        950
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1020, 
        1026
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1040, 
        1050
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 2^9999^MOH|PIMS|CCO-OCR|20160503141800|0042DFD04504A8D0141205796D4D206EFD293C51|ORU^R01|9999999999999999|P|2.5|\nPID|1||999999^^^^CMR^HOSPITAL 2&9999&MOH~999999^^^^MRN^HOSPITAL 2&9999&MOH~9999999999&LL&ON^^^^JHN||XXXXXX-XXXX^XXXXXXX||99999999|F|||99 XXXXXX XX^^XXXXXXX^XX^X9X 9X9^999|||||||||||||||||||N|\nOBR|1||S16-27092|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||201604270000|||71092^XXXXX^XXXXXX||||201604271605|&Breast: U/S GUIDED CORE BX RT BREAST|99999^XXXXX^XXXXXX||||||201604291529||LS|C|||||||99999^XXXXXXXX^XXXXX|\n\n\n\n\n\n\n\nPath report.gross description\n\nThe specimen container labeled with the patient's name and as \"R. uiq 10 cfn\" contains multiple fragments and core-like pieces of yellow-tan tissue ranging in size from 0.3 cm to 1.4 cm in length by 0.1 cm in diameter, received in 10% buffered formalin.\n1A - submitted in toto.\n\n\n\nPath report.site of origin\n\nBreast: U/S GUIDED CORE BX RT BREAST\n\n\nPath report.final diagnosis\n\n\nUltrasound guided needle core biopsy breast mass (Right, 10 O'clock, 10 cm from nipple):\n\n a) Consistent with recurrent/metastatic invasive mammary carcinoma\n  - see comment. .\n\n b) No microcalcifications identified.\n\nCOMMENT: Immunostaining of the tumor for ER/PR/HER2 is pending and an addendum report will be issued once these results are available.\n \n\n\n\nPath report.relevant Hx\n\n\nPathology Breast Biopsy Specimen Requisition Form\n\nClinical Impression:\nUltrasound Guided Core Biopsy\n\nArea of Interest:\nMass   Size: 2 cm\n\nHistory:\nPrevious Breast Cancer: Yes Date metastatic for ca? fr this site \n\nPrevious Therapy: Chemotherapy\n\nBiopsy Site: Right UIQ 10 CFN, 1.9 x 1.4 x 1.9 cm\n\nTime to fixation (time procured to time placed into formalin): 2 minutes.\n\nDate and Time specimen placed into formalin: 27/4/16 @ 1345 hours\n\n\n\nPath report.comments\n\nBIOMARKER STUDIES\n\nBlock / Tumor Stained:   Block: 1A\n   -Tumor: c/w recurrent/metastatic invasive mammary carcinoma\nTEST(S) PERFORMED\nEstrogen Receptor (ER) Status:\n--POSITIVE\n---Tumor cells with Nuclear Positivity:   ----%: 99\n---Average Intensity of Staining:   ----Strong\n-Test Type:   --Laboratory-developed test\n-Primary Antibody:   --SP1\nProgesterone Receptor (PgR) Status:\n--POSITIVE\n---Tumor cells with Nuclear Positivity:   ----%: 25\n---Average Intensity of Staining:   ----Strong\n-Test Type:   --Laboratory-developed test\n-Primary Antibody:   --16\nHER2 by Immunohistochemistry (IHC):\n--EQUIVOCAL (Score 2+)\n-Uniform Intense Complete Membrane Staining (%): 0\n-Test Type:   --Laboratory-developed test\n-Primary Antibody:   --4B5\nMETHODS\nCold Ischemia and Fixation Times:   Meet requirements specified in latest version of the ASCO / CAP Guidelines\nFixative:   Formalin\n\nHER-2/neu gene amplification study by F.I.S.H. is pending and an addendum report will be issued once these results are available.\n\n\n\n"
}